Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Jeffrey H. Davis"'
Autor:
Caridad Martinez, Brent Logan, Xuerong Liu, Christopher C. Dvorak, Lisa Madden, Lyndsay Molinari, Morton J. Cowan, Sung-Yun Pai, Elie Haddad, Jennifer Puck, Donald B. Kohn, Linda M. Griffith, Michael Pulsipher, Jennifer W. Leiding, Luigi D. Notarangelo, Troy Torgerson, Rebecca A. Marsh, Geoff D.E. Cuvelier, Susan Prockop, Rebecca H. Buckley, Caroline Y. Kuo, Alison Yip, Michael S. Hershfield, Roberta E Parrott, Christen L. Ebens, Theodore B. Moore, Richard J. O’Reilly, Malika Kapadia, Neena Kapoor, Lisa Forbes Satter, Lauri M. Burroughs, Aleksandra Petrovic, Monica S. Thakar, Deepak Chellapandian, Jennifer R. Heimall, David C. Shyr, Jeffrey J Bednarski, Ahmad Rayes, Shanmuganathan Chandrakasan, Troy C. Quigg, Blachy J Davila, Kenneth DeSantes, Hesham Eissa, Frederick Goldman, Jacob Rozmus, Ami J Shah, Mark Vander Lugt, Michael D. Keller, Kathleen E. Sullivan, Soma Jyonouchi, Christine Seroogy, Helene Decaluwe, Pierre Teira, Alan P. Knutsen, Morris Kletzel, Victor Aquino, Jeffrey H Davis, Paul Szabolcs
Publikováno v:
Transplantation and Cellular Therapy. 29:S91-S93
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0824a310f115e5aa7f4a806f6f069dfa
https://doi.org/10.1016/s2666-6367(23)00185-9
https://doi.org/10.1016/s2666-6367(23)00185-9
Autor:
Juan Carlos Fierro-Pineda, Hua-Ling Tsai, Amanda L Blackford, Andrew Cluster, Emi H Caywood, Jignesh Dalal, Jeffrey H Davis, R. Maarten Egeler, Jeffrey Huo, Michelle Hudspeth, Amy K. Keating, Susan S Kelly, Joerg Krueger, Dean A Lee, Leslie Elaine Lehmann, Lisa Madden, Benjamin R Oshrine, Michael A Pulsipher, Terry J Fry, Heather J Symons
Publikováno v:
Blood Advances.
Promising results have been reported for adult patients with high-risk hematologic malignancies undergoing haploidentical bone marrow transplant (haploBMT) with post-transplantation cyclophosphamide (PTCy). We report results from the first multicente
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ea4e6f0d0b7c5850d1fe70db1cd3feb
https://doi.org/10.1182/bloodadvances.2023010281
https://doi.org/10.1182/bloodadvances.2023010281
Autor:
Kathryn Trinkaus, Martin Andreansky, Jeffrey J. Bednarski, Sima T. Bhatt, Jignesh Dalal, Ka Wah Chan, Michael A. Pulsipher, Roberta H. Adams, Michael Grimley, Jennifer Joi Jaroscak, Ginny Schulz, Naynesh Kamani, David A. Jacobsohn, Jennifer Willert, Monica Hente, Paul R. Haut, Sonali Chaudhury, Gregory A. Hale, Michael Nieder, Shalini Shenoy, Julia Berg, Lolie Yu, Jeffrey H. Davis, Robert J. Hayashi, Lisa Murray
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:556-561
Hematopoietic stem cell transplantation (HSCT) is a therapeutic option for many nonmalignant disorders (NMD) and is curative or prevents disease progression. Reduced-intensity conditioning (RIC) in HSCT for NMD may reduce regimen-related acute toxici
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36c99e2c5eab98ccdc44feec942cccd1
https://doi.org/10.1016/j.bbmt.2018.10.008
https://doi.org/10.1016/j.bbmt.2018.10.008
Autor:
Yvonne Suessmuth, Shalini Shenoy, Catherine Bresee, Alison Yu, Amelia Langston, Scott N. Furlan, Andrew C. Harris, Steven E. Bosinger, Muna Qayed, Sungjin Kim, Brandi Bratrude, Maxim Norkin, Audrey G. Tumlin, Jeffrey H. Davis, James Rhodes, John T. Horan, Courtney McCracken, Urvi Kapoor, Alexandria Narayan, Leslie S. Kean, Kayla Betz, Benjamin Watkins, John E. Levine, Bruce R. Blazar, Aleksandra Petrovic, Sung Won Choi, Kayla Cribbin, Michael Grimley, James L.M. Ferrara, Scott Gillespie, Kyle Hebert, Ted Gooley, Marcelo C. Pasquini, Shauna Sinclair, Michael A. Pulsipher, Mourad Tighiouart, Roger Giller, David A. Jacobsohn, Nahal R. Lalefar, Kirk R. Schultz, Christine Duncan, Edmund K. Waller, Gregory A. Yanik, Victor Tkachev, Andre Rogatko, Nosha Farhadfar
Publikováno v:
J Clin Oncol
PURPOSE Severe (grade 3-4) acute graft-versus-host disease (AGVHD) is a major cause of death after unrelated-donor (URD) hematopoietic cell transplant (HCT), resulting in particularly high mortality after HLA-mismatched transplantation. There are no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6ef7b7224dca5b8fd51b3c034d8c0f2
https://pubmed.ncbi.nlm.nih.gov/33449816
https://pubmed.ncbi.nlm.nih.gov/33449816
Autor:
Harry L. Malech, Roberta E. Parrott, Evan Shereck, Kenneth B. DeSantes, Troy C. Quigg, Thomas A. Fleisher, Alfred P. Gillio, Rebecca H. Buckley, Richard J. O'Reilly, Sung-Yun Pai, Luigi D. Notarangelo, Victor M. Aquino, Morton J. Cowan, Jeffrey J. Bednarski, Jennifer M. Puck, Donald B. Kohn, David C. Shyr, Soma Jyonouchi, Imelda C. Hanson, Pierre Teira, Matthew H. Porteus, Angela R. Smith, Paul Szabolcs, Candace Taylor, Jeffrey H. Davis, Mark Vander Lugt, Jack J. Bleesing, Morris Kletzel, Hélène Decaluwe, Megan Murnane, Christine M. Seroogy, Trudy N. Small, James A. Connelly, Audrey G. Tumlin, Sharat Chandra, Matthew E. Cavanaugh, Kathleen E. Sullivan, Ann E. Haight, Aleksandra Petrovic, Linda M. Griffith, Neena Kapoor, Brent R. Logan, John Craddock, Susan E. Prockop, Michael A. Pulsipher, Michael D. Keller, Geoffrey D.E. Cuvelier, Caridad Martinez, Jessica Chaisson, Frederick D. Goldman, Alan P. Knutsen, Monica S. Thakar, Lolie C. Yu, Ziyan Yin, Lauri Burroughs, William T. Shearer, Hisham Abdel-Azim, Jennifer W. Leiding, Jennifer Heimall, Elie Haddad, Christopher C. Dvorak, Theodore B. Moore, Blachy J. Dávila Saldaña, Elizabeth M. Kang, Suzanne Skoda-Smith
Publikováno v:
Blood. 132:1737-1749
The Primary Immune Deficiency Treatment Consortium (PIDTC) performed a retrospective analysis of 662 patients with severe combined immunodeficiency (SCID) who received a hematopoietic cell transplantation (HCT) as first-line treatment between 1982 an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77d6ef98c53eabc748b1041f481c507e
https://doi.org/10.1182/blood-2018-03-840702
https://doi.org/10.1182/blood-2018-03-840702
Autor:
Alexia Adams, Sanjay P Ahuja, Alfred P. Gillio, Roberta H. Adams, Lisa Eidenschink Brodersen, Sureyya Savasan, Mingwei Fei, Michael R. Loken, Michael A. Pulsipher, Kwang Woo Ahn, Morris Kletzel, David A. Jacobsohn, Pierre Teira, Barbara Bambach, Jeffrey H. Davis, David C. Delgado, Ann E. Haight, Reggie E. Duerst, Allen R. Chen, Mehmet Ozkaynak, Christopher C. Dvorak, Kimberly A. Kasow, Soheil Meshinchi, Troy C. Quigg, Madhu Gowda, Brent R. Logan, Julie-An Talano, Kirk R. Schultz, Victor Lewis, Bronwen E. Shaw, Michael Boyer, David Mitchell, David M. Loeb, Albert Kheradpour, Andrew C. Harris, Hilary Haines, Eneida R. Nemecek, Amy K. Keating, Shalini Shenoy, Robert J. Greiner, Aleksandra Petrovic, Marie Olszewski, Paul L. Martin, Terry J. Fry, Michelle Hudspeth, Alexandra Cheerva, Sana Khan, Monica Bhatia, Steven P. Margossian
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, vol 24, iss 10
We enrolled 150 patients in a prospective multi-center study of children with acute myeloid leukemia undergoing hematopoietic stem cell transplant (HSCT) comparing detection of measurable residual (MRD) disease by a “Difference from Normal” flow
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a379020b8e9c1b95677d4639bd292a8
https://doi.org/10.1016/j.bbmt.2018.06.010
https://doi.org/10.1016/j.bbmt.2018.06.010
Autor:
Kayla Betz, Chao Zhang, John T. Horan, Nahal R. Lalefar, Aleksandra Petrovic, Catherine Bresee, Leslie S. Kean, Scott Gillespie, Nosha Farhadfar, Edmund K. Waller, Gregory A. Yanik, David A. Jacobsohn, Yvonne Suessmuth, Roger Giller, James Rhodes, Christine Duncan, Sungjin Kim, Mourad Tighiouart, Shalini Shenoy, Jeffrey H. Davis, Sung Choi, Muna Qayed, Mike A. Pulsipher, Benjamin Watkins, Brandi Bratrude, Courtney McCracken, Alison Yu, Kirk R. Schultz, Michael Grimley, Andre Rogatko, Scott N. Furlan, Amelia Langston, Andrew C. Harris, Bruce R. Blazar, Kayla Cribbin, Maxim Norkin
Publikováno v:
Transplantation and Cellular Therapy. 27:S32-S33
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a9544caabbea38ba3536456d074011c4
https://doi.org/10.1016/s2666-6367(21)00059-2
https://doi.org/10.1016/s2666-6367(21)00059-2
Autor:
Jeffrey H. Davis, Fahed Halal, Kimberly I. Seath, Avi Saskin, Frédérique Tihy, Emmanuelle Lemyre, Linlea Armstrong
Publikováno v:
Cancer genetics.
Ewing sarcoma (ES), a common pediatric primary bone neoplasm, has a well-defined genomic landscape with various predisposing genomic elements including TP53, PMS2 and RET. Additionally, germline and somatic variants in protein tyrosine phosphatase de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b691e68dfd99a5125b5113858504a9b
https://pubmed.ncbi.nlm.nih.gov/31072725
https://pubmed.ncbi.nlm.nih.gov/31072725
Autor:
Mignon L. Loh, Jeffrey H. Davis, Rochelle Yanofsky, Tamara Lamprecht, Paul Rogers, James R. Downing, Sara J. Israels, Jason R. Schwartz, Victoria Bryant, Jeffery M. Klco, Maria del pilar Alzamora, Michael Walsh, Raul C. Ribeiro, Kevin Shannon, Stuart H. Gold, Jing Ma, Jasmine C. Wong, Charles G. Mullighan, William L. Carroll
Publikováno v:
JCI insight. 3(14)
Germline SAMD9 and SAMD9L mutations cause a spectrum of multisystem disorders that carry a markedly increased risk of developing myeloid malignancies with somatic monosomy 7. Here, we describe 16 siblings, the majority of which were phenotypically no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18a371a77b964ce2f149ee139aacd12e
https://pubmed.ncbi.nlm.nih.gov/30046003
https://pubmed.ncbi.nlm.nih.gov/30046003
Autor:
Kayla Cribbin, Carol Dean, Alexandria Narayan, Kayla Betz, Aleksandra Petrovic, Maxim Norkin, Amelia Langston, Andrew C. Harris, Jeffrey H. Davis, David A. Jacobsohn, Mourad Tighiouart, Bruce R. Blazar, Leslie S. Kean, Andre Rogatko, Kyle Hebert, Michael A. Pulsipher, Catherine Bresee, Yvonne Suessmuth, Alison Yu, Sungjin Kim, Anglea Banks, Michael Grimley, C.N. Duncan, Shalini Shenoy, Kirk R. Schultz, James Rhodes, Marcelo C. Pasquini, Sung Choi, Daniel J. Hunt, Nahal R. Lalefar, Ben Watkins, Muna Qayed, Shauna Sinclair, John T. Horan, Brandi Bratrude, Scott Gillespie, Naomi Schwartz, Roger Giller
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S51-S52
We performed a Ph2 trial in adults and children to test abatacept for AGVHD prevention (‘ABA2', Clinicaltrials # NCT01743131), based on our promising preclinical and pilot patient data. ABA2 had 2 cohorts: A) HLA-mismatched (‘7/8', n = 43), a sin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f5179f4ebce286dc76ae961458193dd7
https://doi.org/10.1016/j.bbmt.2018.12.129
https://doi.org/10.1016/j.bbmt.2018.12.129